Penumbra Change in Accounts Receivable 2014-2025 | PEN

Penumbra change in accounts receivable for the twelve months ending June 30, 2025 was $0.046B, a 10520.27% decline year-over-year.

  • Penumbra annual change in accounts receivable for 2024 was $0.027B, a 10098.87% decline from 2023.
  • Penumbra annual change in accounts receivable for 2023 was $-0B, a 99.62% decline from 2022.
  • Penumbra annual change in accounts receivable for 2022 was $-0.07B, a 227.29% increase from 2021.

Penumbra Change in Accounts Receivable 2014-2025 | PEN

  • Penumbra annual change in accounts receivable for 2024 was $0.027B, a 10098.87% decline from 2023.
  • Penumbra annual change in accounts receivable for 2023 was $-0B, a 99.62% decline from 2022.
  • Penumbra annual change in accounts receivable for 2022 was $-0.07B, a 227.29% increase from 2021.
Related Stocks
Company NameMarket
Cap
Thermo Fisher Scientific (TMO)$184.5B
Intuitive Surgical (ISRG)$170B
IDEXX Laboratories (IDXX)$51.3B
Edwards Lifesciences (EW)$47.7B
Alcon (ALC)$40.2B
IQVIA Holdings (IQV)$31.9B
DexCom (DXCM)$29.9B
Mettler-Toledo (MTD)$26.5B
STERIS (STE)$24.5B
Waters (WAT)$17.6B
SONOVA HOLDING (SONVY)$16.9B
Hologic (HOLX)$14.8B
Globus Medical (GMED)$8.4B
Sysmex ADR (SSMXY)$8.1B
Masimo (MASI)$7.8B
Teleflex (TFX)$5.6B
Glaukos (GKOS)$5.4B
TransMedics (TMDX)$3.9B
Integer Holdings (ITGR)$3.8B
LivaNova (LIVN)$3.1B
Alphatec Holdings (ATEC)$2.4B
Veracyte (VCYT)$2.3B
PROCEPT BioRobotics (PRCT)$2.3B
Artivion (AORT)$2.1B
Nihon Kohden (NHNKY)$1.9B
Elekta AB (EKTAY)$1.9B
Integra LifeSciences Holdings (IART)$1.1B
Pulse Biosciences (PLSE)$1.1B
OPKO Health (OPK)$1.1B
Paragon 28 (FNA)$1.1B